Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Using the Cholinergic Anti-Inflammatory Pathway to Treat Systemic Lupus Musculoskeletal Pain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02822989
Recruitment Status : Enrolling by invitation
First Posted : July 6, 2016
Last Update Posted : September 9, 2020
Sponsor:
Collaborator:
John and Marcia Goldman Foundation
Information provided by (Responsible Party):
Cynthia Aranow, MD, Northwell Health

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Enrolling by invitation
Actual Primary Completion Date : April 30, 2018
Estimated Study Completion Date : November 1, 2020
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 December 1, 2020
December 24, 2020